• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口蹄疫病毒 VP1 G-H 环缺失部分具有标记疫苗潜力。

Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.

机构信息

Institute for Animal Health, Pirbright Laboratory, Ash Road, Surrey, GU24 0NF, UK.

出版信息

Vaccine. 2010 Apr 26;28(19):3428-34. doi: 10.1016/j.vaccine.2010.02.074. Epub 2010 Mar 1.

DOI:10.1016/j.vaccine.2010.02.074
PMID:20199761
Abstract

Previous work in cattle and pigs demonstrated that protection against foot-and-mouth disease (FMD) could be achieved following vaccination with chimeric foot-and-mouth disease virus (FMDV) vaccines, in which the VP1 G-H loop had been substituted with that from another serotype. This indicated that the VP1 G-H loop may not be essential for the protection of natural hosts against FMDV. If this could be substantiated there would be potential to develop FMD marker vaccines, characterised by the absence of this region. Here, we investigate the serological responses to vaccination with a virus with a partial VP1 G-H loop deletion in order to determine the likelihood of achieving protection and the potential of this virus as a marker vaccine. Inactivated, oil adjuvanted, vaccines, consisting of chemically inactivated virus with or without a partially deleted VP1 G-H loop, were used to immunise cattle. Serum was collected on days 0, 7, 14 and 21 and antibody titres calculated using the virus neutralisation test (VNT) to estimate the likelihood of protection. We predict a good likelihood that cattle vaccinated with a vaccine characterised by a partial VP1 G-H loop would be protected against challenge with the same virus containing the VP1 G-H loop. We also present evidence on the potential of such a construct to act as a marker vaccine, when used in conjunction with a novel serological test.

摘要

先前在牛和猪身上的研究工作表明,用嵌合口蹄疫病毒(FMDV)疫苗接种可以实现对口蹄疫(FMD)的保护,其中 VP1 G-H 环已被另一种血清型取代。这表明 VP1 G-H 环对于保护自然宿主免受 FMDV 的侵害可能不是必需的。如果这可以得到证实,那么开发 FMD 标记疫苗就有了潜力,其特征是缺少这一区域。在这里,我们研究了接种具有部分 VP1 G-H 环缺失的病毒后的血清学反应,以确定实现保护的可能性以及该病毒作为标记疫苗的潜力。使用化学灭活的病毒和/或具有部分缺失的 VP1 G-H 环的油佐剂灭活疫苗来免疫牛。在第 0、7、14 和 21 天收集血清,并使用病毒中和试验(VNT)计算抗体滴度,以估计保护的可能性。我们预测,接种具有部分 VP1 G-H 环的疫苗的牛很有可能在接种含有 VP1 G-H 环的相同病毒时受到保护。我们还提供了证据,证明在与新型血清学测试结合使用时,这种构建体有可能作为一种标记疫苗。

相似文献

1
Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.口蹄疫病毒 VP1 G-H 环缺失部分具有标记疫苗潜力。
Vaccine. 2010 Apr 26;28(19):3428-34. doi: 10.1016/j.vaccine.2010.02.074. Epub 2010 Mar 1.
2
Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.嵌合口蹄疫病毒:其作为牛潜在标记疫苗的效力评估
Vaccine. 2008 Apr 7;26(16):1982-9. doi: 10.1016/j.vaccine.2008.02.012. Epub 2008 Feb 22.
3
Foot-and-mouth disease marker vaccine: cattle protection with a partial VP1 G-H loop deleted virus antigen.口蹄疫标记疫苗:用缺失 VP1 G-H 环的部分病毒抗原保护牛。
Vaccine. 2011 Oct 26;29(46):8405-11. doi: 10.1016/j.vaccine.2011.08.035. Epub 2011 Aug 19.
4
Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.定制工程嵌合口蹄疫疫苗在猪中引发保护性免疫应答。
J Gen Virol. 2011 Apr;92(Pt 4):849-59. doi: 10.1099/vir.0.027151-0. Epub 2010 Dec 22.
5
Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.控制口蹄疫新策略的研发:标记疫苗和抗病毒药物。
Biologicals. 2005 Dec;33(4):227-34. doi: 10.1016/j.biologicals.2005.08.009. Epub 2005 Nov 14.
6
Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge.血清型内SAT2嵌合口蹄疫疫苗可保护牛抵御口蹄疫病毒攻击。
Vaccine. 2015 Jun 9;33(25):2909-16. doi: 10.1016/j.vaccine.2015.04.058. Epub 2015 Apr 27.
7
An approach to a FMD vaccine based on genetic engineered attenuated pseudorabies virus: one experiment using VP1 gene alone generates an antibody responds on FMD and pseudorabies in swine.一种基于基因工程减毒伪狂犬病病毒的口蹄疫疫苗研发方法:仅使用VP1基因进行的一项实验可在猪体内引发针对口蹄疫和伪狂犬病的抗体反应。
Vaccine. 2004 Jun 2;22(17-18):2129-36. doi: 10.1016/j.vaccine.2003.12.005.
8
Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.水疱性口炎病毒糖蛋白 G 携带口蹄疫病毒抗原位点 A 的串联二聚体可作为牛的 DNA 和肽疫苗使用。
Antiviral Res. 2011 Nov;92(2):219-27. doi: 10.1016/j.antiviral.2011.08.006. Epub 2011 Aug 26.
9
Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.共表达口蹄疫病毒VP1和猪α干扰素的重组腺病毒在小鼠和豚鼠体内的免疫反应
Vet Immunol Immunopathol. 2008 Aug 15;124(3-4):274-83. doi: 10.1016/j.vetimm.2008.04.011. Epub 2008 Apr 22.
10
Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.用表达口蹄疫病毒衣壳前体编码区的减毒重组伪狂犬病病毒免疫猪诱导保护性免疫。
Vaccine. 2008 May 23;26(22):2714-22. doi: 10.1016/j.vaccine.2008.03.020. Epub 2008 Apr 1.

引用本文的文献

1
Levamisole, as a viral vaccine adjuvant, induces robust host defense through the modulation of innate and adaptive immune responses.左旋咪唑作为一种病毒疫苗佐剂,通过调节先天性和适应性免疫反应诱导强大的宿主防御。
Front Microbiol. 2025 Jan 8;15:1493561. doi: 10.3389/fmicb.2024.1493561. eCollection 2024.
2
Next-generation adjuvant systems containing furfurman drives potent adaptive immunity and host defense as a foot-and-mouth disease vaccine adjuvant.含有糠醛的下一代佐剂系统作为口蹄疫疫苗佐剂可驱动强大的适应性免疫和宿主防御。
Front Immunol. 2024 Dec 11;15:1491043. doi: 10.3389/fimmu.2024.1491043. eCollection 2024.
3
Enhanced Effects of ISA 207 Adjuvant via Intradermal Route in Foot-and-Mouth Disease Vaccine for Pigs.
ISA 207佐剂经皮内途径对猪口蹄疫疫苗的增强作用。
Vaccines (Basel). 2024 Aug 26;12(9):963. doi: 10.3390/vaccines12090963.
4
Isoprinosine as a foot-and-mouth disease vaccine adjuvant elicits robust host defense against viral infection through immunomodulation.免疫刺激剂异丙肌苷作为口蹄疫疫苗佐剂通过免疫调节激发针对病毒感染的强烈宿主防御。
Front Cell Infect Microbiol. 2024 Mar 6;14:1331779. doi: 10.3389/fcimb.2024.1331779. eCollection 2024.
5
D-galacto-D-mannan-mediated Dectin-2 activation orchestrates potent cellular and humoral immunity as a viral vaccine adjuvant.D-半乳糖-D-甘露聚糖介导的Dectin-2激活作为一种病毒疫苗佐剂,可协调强大的细胞免疫和体液免疫。
Front Immunol. 2024 Feb 16;15:1330677. doi: 10.3389/fimmu.2024.1330677. eCollection 2024.
6
Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease.含甘草酸佐剂的灭活疫苗可引发针对口蹄疫的强大天然免疫和适应性免疫反应。
Front Microbiol. 2023 Oct 31;14:1289065. doi: 10.3389/fmicb.2023.1289065. eCollection 2023.
7
Bestatin, A Pluripotent Immunomodulatory Small Molecule, Drives Robust and Long-Lasting Immune Responses as an Adjuvant in Viral Vaccines.贝司他汀,一种多能免疫调节小分子,作为病毒疫苗的佐剂可激发强大且持久的免疫反应。
Vaccines (Basel). 2023 Nov 4;11(11):1690. doi: 10.3390/vaccines11111690.
8
Dectin-1 signaling coordinates innate and adaptive immunity for potent host defense against viral infection.Dectin-1 信号转导协调固有和适应性免疫,以有效抵抗病毒感染。
Front Immunol. 2023 Jun 2;14:1194502. doi: 10.3389/fimmu.2023.1194502. eCollection 2023.
9
The C3d-fused foot-and-mouth disease vaccine platform overcomes maternally-derived antibody interference by inducing a potent adaptive immunity.C3d融合口蹄疫疫苗平台通过诱导强大的适应性免疫克服母源抗体干扰。
NPJ Vaccines. 2022 Jun 28;7(1):70. doi: 10.1038/s41541-022-00496-8.
10
Age-Dependent Dynamics of Maternally Derived Antibodies (MDAs) and Understanding MDA-Mediated Immune Tolerance in Foot-and-Mouth Disease-Vaccinated Pigs.母源抗体(MDAs)的年龄依赖性动态变化以及对口蹄疫疫苗接种猪中MDA介导的免疫耐受的理解
Vaccines (Basel). 2022 Apr 24;10(5):677. doi: 10.3390/vaccines10050677.